Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Norman Isaac Heching
Observed names:
N Heching,
N. Heching,
Norman Heching,
Norman I. Heching
Institutions:
Shaare Zedek Medical Center,
Bikur Cholim Hospital
Observed institutions:
The University of Western Australia,
Hebrew University of Jerusalem,
Hadassah Medical Center,
Shaare Zedek Medical Center,
Bikur Cholim Hospital
OpenAlex ID:
A5085568241
Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial
2019
·
Luis Paz-Ares
, Mikhail Dvorkin
, et al.
·
The Lancet
·
2,281
Durvalumab, with or without tremelimumab, plus platinum–etoposide versus platinum–etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trial
2020
·
Jonathan W Goldman
, Mikhail Dvorkin
, et al.
·
The Lancet Oncology
·
688
First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials
2017
·
Harpreet S Wasan
, Peter Gibbs
, et al.
·
The Lancet Oncology
·
403
PDF
The founder mutations 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2 appear in 60% of ovarian cancer and 30% of early-onset breast cancer patients among Ashkenazi women.
1997
·
D Abeliovich
, L Kaduri
, et al.
·
PubMed
·
358
Evaluation of tissue polypeptide specific antigen, CYFRA 21-1, and carcinoembryonic antigen in nonsmall cell lung carcinoma
1998
·
Benjamin Nisman
, Joel Lafair
, et al.
·
Cancer
·
111
PDF
Leptomeningeal metastases: evaluation by gadolinium enhanced spinal magnetic resonance imaging
1998
·
John M. Gomori
, Norman Heching
, et al.
·
Journal of Neuro-Oncology
·
74
Effect of Primary Tumor Side on Survival Outcomes in Untreated Patients With Metastatic Colorectal Cancer When Selective Internal Radiation Therapy Is Added to Chemotherapy: Combined Analysis of Two Randomized Controlled Studies
2018
·
Peter Gibbs
, Volker Heinemann
, et al.
·
Clinical Colorectal Cancer
·
68
The diagnostic and prognostic value of ProGRP in lung cancer.
2009
·
Benjamin Nisman
, Haim Biran
, et al.
·
PubMed
·
66
Dexrazoxane added to doxorubicin-based adjuvant chemotherapy of breast cancer
2017
·
Esther Tahover
, Amiel Segal
, et al.
·
Anti-Cancer Drugs
·
52
Prognostic value of CYFRA 21-1, TPS and CEA in different histologic types of non-small cell lung cancer.
2000
·
B Nisman
, G Amir
, et al.
·
PubMed
·
44
The Prognostic Significance of Circulating Neuroendocrine Markers Chromogranin A, Pro-Gastrin-Releasing Peptide and Neuron-Specific Enolase in Patients with Advanced Non-Small-Cell Lung Cancer
2005
·
Benjamin Nisman
, Norman Heching
, et al.
·
Tumor Biology
·
37
Prognostic role of serum cytokeratin 19 fragments in advanced non-small-cell lung cancer: association of marker changes after two chemotherapy cycles with different measures of clinical response and survival
2007
·
B Nisman
, H Biran
, et al.
·
British Journal of Cancer
·
30
PDF
Computed Tomography Screening for Lung Cancer: Applicability of an International Protocol in a Single-Institution Environment
2006
·
Dorith Shaham
, Raphael Breuer
, et al.
·
Clinical Lung Cancer
·
25
Neoadjuvant Osimertinib Followed by Sequential Definitive Radiation Therapy and/or Surgery in Stage III Epidermal Growth Factor Receptor–Mutant Non-Small Cell Lung Cancer: An Open-Label, Single-Arm, Phase 2 Study
2023
·
Nir Peled
, Laila C. Roisman
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
·
23
Genetic testing of breast and ovarian cancer patients: clinical characteristics and hormonal risk modifiers
1999
·
Luna Kaduri
, Maya Gibs
, et al.
·
European Journal of Obstetrics & Gynecology and Reproductive Biology
·
10
Cytokeratin Markers in Malignant Pleural Mesothelioma
1998
·
Benjamin Nisman
, Vivian Barak
, et al.
·
Cancer Detection and Prevention
·
10
P4.07D.01 Neoadjuvant Osimertinib Followed by Radiation And/or Surgery in Stage III EGFR-Mutant NSCLC: An Open-Label, Single-Arm, Phase 2 Study
2024
·
N. Peled
, W. Kian
, et al.
·
Journal of Thoracic Oncology
·
1
PDF
[fdg Pet/ct for Treatment Response Assessment in Cancer].
2021
·
Rachel Bar-Shalom
, Ora Rosengarten
, et al.
·
PubMed
·
1
EP12.01-76 Adding Amivantamab as a Salvage Strategy Post EGFR TKI (Osimertinib/Mobocertinib) in EGFRm+ NSCLC
2023
·
B.J. krayim
, W. Kian
, et al.
·
Journal of Thoracic Oncology
PDF
1343P Amivantimab as a salvage strategy post TKI (osimertinib/mobocertinib) in EGFRm NSCLC
2023
·
B.J. Krayim
, W. Kian
, et al.
·
Annals of Oncology
PDF
Intravascular Small Cell Carcinoma Disguised as Pulmonary Embolism.
2021
·
Ariel Rokach
, Sarit Hochberg-Klein
, et al.
·
PubMed
[Genetic counseling for families at high cancer risk].
1996
·
M Sagi
, N Heching
, et al.
·
PubMed
A multiparous pregnant woman receiving chemotherapy for breast cancer
1995
·
Y. Cass
, B. Uziely
, et al.
·
Journal of Oncology Pharmacy Practice
Show more works
View as search
Works count:
24
Citation count:
4,682
H-index:
15
I10-index:
17
Year
Topic
Type
